Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study.

FRONTOTEMPORAL DEMENTIA GENETICS INCL BODY MYOSITIS MUSCLE DISEASE MYOPATHY

Journal

Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R

Informations de publication

Date de publication:
27 07 2022
Historique:
received: 01 02 2022
accepted: 28 06 2022
pmc-release: 27 01 2024
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: aheadofprint

Résumé

Valosin-containing protein (VCP) disease, caused by mutations in the Descriptive retrospective international study collecting clinical and genetic data of patients with mutations in the Two hundred and fifty-five patients (70.0% males) were included in the study. Mean age was 56.8±9.6 years and mean age of onset 45.6±9.3 years. Mean diagnostic delay was 7.7±6 years. Symmetric lower limb weakness was reported in 50% at onset progressing to generalised muscle weakness. Other common symptoms were ventilatory insufficiency 40.3%, PDB 28.2%, dysautonomia 21.4% and FTD 14.3%. Fifty-seven genetic variants were identified, 18 of these no previously reported. c.464G>A (p.Arg155His) was the most frequent variant, identified in the 28%. Full time wheelchair users accounted for 19.1% with a median time from disease onset to been wheelchair user of 8.5 years. Variant c.463C>T (p.Arg155Cys) showed an earlier onset (37.8±7.6 year) and a higher frequency of axial and upper limb weakness, scapular winging and cognitive impairment. Forced vital capacity (FVC) below 50% was as risk factor for being full-time wheelchair user, while FVC <70% and being a full-time wheelchair user were associated with death. This study expands the knowledge on the phenotypic presentation, natural history, genotype-phenotype correlations and risk factors for disease progression of VCP disease and is useful to improve the care provided to patient with this complex disease.

Sections du résumé

BACKGROUND
Valosin-containing protein (VCP) disease, caused by mutations in the
METHODS
Descriptive retrospective international study collecting clinical and genetic data of patients with mutations in the
RESULTS
Two hundred and fifty-five patients (70.0% males) were included in the study. Mean age was 56.8±9.6 years and mean age of onset 45.6±9.3 years. Mean diagnostic delay was 7.7±6 years. Symmetric lower limb weakness was reported in 50% at onset progressing to generalised muscle weakness. Other common symptoms were ventilatory insufficiency 40.3%, PDB 28.2%, dysautonomia 21.4% and FTD 14.3%. Fifty-seven genetic variants were identified, 18 of these no previously reported. c.464G>A (p.Arg155His) was the most frequent variant, identified in the 28%. Full time wheelchair users accounted for 19.1% with a median time from disease onset to been wheelchair user of 8.5 years. Variant c.463C>T (p.Arg155Cys) showed an earlier onset (37.8±7.6 year) and a higher frequency of axial and upper limb weakness, scapular winging and cognitive impairment. Forced vital capacity (FVC) below 50% was as risk factor for being full-time wheelchair user, while FVC <70% and being a full-time wheelchair user were associated with death.
CONCLUSION
This study expands the knowledge on the phenotypic presentation, natural history, genotype-phenotype correlations and risk factors for disease progression of VCP disease and is useful to improve the care provided to patient with this complex disease.

Identifiants

pubmed: 35896379
pii: jnnp-2022-328921
doi: 10.1136/jnnp-2022-328921
pmc: PMC9880250
mid: NIHMS1851561
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAMS NIH HHS
ID : K24 AR073317
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG031867
Pays : United States
Organisme : NINDS NIH HHS
ID : U24 NS120858
Pays : United States

Investigateurs

Adolfo López de Munain (AL)
Alba Ramos-Fransi (A)
Aleksandra Nadaj-Pakleza (A)
Alicia Alonso-Jiménez (A)
Alicia Martinez-Piñeiro (A)
Ana Töpf (A)
Anders Oldfors (A)
Anna Kaminska (A)
Anna Kostera-Pruszczyk (A)
Anna Mayhew (A)
Anna Rydelius (A)
Anthony Behin (A)
Antonio Toscano (A)
Aurelio Hernández Laín (A)
Beatrice Lannes (B)
Beatriz Velez (B)
Benedikt Schoser (B)
Biruta Kierdaszuk (B)
Bjarne Udd (B)
Boel De Paepe (B)
Bruno Eymard (B)
Carla Marco Cazcarra (CM)
Carmelo Rodolico (C)
Carmen Paradas (C)
Carola Hedberg-Oldfors (C)
Channa Hewamadduma (C)
Cheryl Longman (C)
Chiara Marini Bettollo (CM)
Chiseko Ikenaga (C)
Christopher Nance (C)
Colin Quinn (C)
Conrad Weihl (C)
Constantinos Papadopoulos (C)
Corinne Metay (C)
Cristina Domínguez-González (C)
David Hilton-Jones (D)
Edmar Zanotelli (E)
Edoardo Malfatti (E)
Elena Pegoraro (E)
Elizabeth A Harrington (EA)
Ellen Eline (E)
Ellen Gelpi (E)
Eloy Rivas (E)
Endre Pál (E)
Francesc Miralles (F)
George K Papadimas (GK)
Gergious Manousakis (G)
Gianni Sorarù (G)
Giorgio Tasca (G)
Giulia Bisogni (G)
Giuseppe Lucente (G)
Hakan Cetin (H)
Hani Kushlaf (H)
Ichizo Nishino (I)
Jan L De Bleecker (JL)
Jean François (J)
Jean-Baptiste Chanson (JB)
Jie Lin (J)
Jin-Hong Shin (JH)
Jodi Warman (J)
Johanna Palmio (J)
Jonathan Baets (J)
Jordi Díaz-Manera (J)
Jorge A Bevilacqua (JA)
Jorge Alonso Pérez (JA)
Jorge Díaz (J)
Jorge García-García (J)
Juan J Vilchez (JJ)
Judith Hudson (J)
Kinga Hadzsiev (K)
Kristl G Claeys (KG)
Lindsay N Alfano (LN)
Luca Bello (L)
Maria Elena Farrugia (ME)
Marianela Schiava (M)
Marianne de Visser (M)
Mario Campero (M)
Mario Sabatelli (M)
Marion Masingue (M)
Marta Caballero-Ávila (M)
Matthew B Harms (MB)
Matthias Vorgerd (M)
Mauro Monforte (M)
Meredith James (M)
Michela Guglieri (M)
Michio Inoue (M)
Mónica Povedano (M)
Monika Hofer (M)
Montse Olivé (M)
Natalia Garcia-Angarita (N)
Nicholas Earle (N)
Noemi Vidal Sarró (NV)
Nuria Muelas (N)
Pascal Lafôret (P)
Pascale Rihard (P)
Paulo Vs Souza (PV)
Peter de Jonghe (P)
Phillipa J Lamont (PJ)
Pietro Riguzzi (P)
Pilar Camaño (P)
Raúl Domínguez Rubio (RD)
Robert Carlier (R)
Robert Muni-Lofra (R)
Roberto Fernández-Torrón (R)
Rocío Nur Villar-Quiles (RN)
Rodrigo Alvarez (R)
Rudi Kley (R)
Sabine Krause (S)
Sarah Leonard-Louis (S)
Sarah Souvannanorath (S)
Sigrid Klotz (S)
Simone Thiele (S)
Sofia Xirou (S)
Sruthi S Nair (SS)
Stefen Brady (S)
Stojan Peric (S)
Stuart Ralston (S)
Sushan Luo (S)
Tanya Stojkovic (T)
Teresinha Evangelista (T)
Thomas E Lloyd (TE)
Tiffany Grider (T)
Timothy Williams (T)
Umesh Badrising (U)
Velina Nedkova-Hristova (V)
Vidosava Rakocevic-Stojanovic (V)
Virginia Kimonis (V)
Volker Straub (V)
Wenhua Zhu (W)
Willem de Ridder (W)
William Kelly (W)
Yoshihiko Saito (Y)
Young-Eun Park (YE)
Yukako Nishimori (Y)
Zarife Sahenk (Z)

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Genet Med. 2000 Jul-Aug;2(4):232-41
pubmed: 11252708
Hum Mutat. 2013 Aug;34(8):1111-8
pubmed: 23606453
Neuromuscul Disord. 2020 Mar;30(3):232-235
pubmed: 32165109
Case Rep Genet. 2019 Oct 9;2019:2403024
pubmed: 31687228
Endocrinology. 2021 Nov 1;162(11):
pubmed: 34467976
Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5-6):291-2
pubmed: 26121170
J Neurol Neurosurg Psychiatry. 2009 May;80(5):583-4
pubmed: 19372299
JAMA Neurol. 2016 Sep 1;73(9):1105-14
pubmed: 27400454
Clin Genet. 2018 Jan;93(1):119-125
pubmed: 28692196
Handb Clin Neurol. 2013;115:115-36
pubmed: 23931777
Orphanet J Rare Dis. 2020 Sep 29;15(1):267
pubmed: 32993728
Neurology. 2020 Feb 25;94(8):e785-e796
pubmed: 31848255
Clin Genet. 2013 May;83(5):422-31
pubmed: 22909335
Orphanet J Rare Dis. 2022 Jan 29;17(1):23
pubmed: 35093159
Neuromuscul Disord. 2011 Aug;21(8):551-5
pubmed: 21684747
Muscle Nerve. 2014 Aug;50(2):295-9
pubmed: 24838343
Int J Mol Sci. 2020 May 28;21(11):
pubmed: 32481679
Neuron. 2010 Dec 9;68(5):857-64
pubmed: 21145000
Nat Genet. 2004 Apr;36(4):377-81
pubmed: 15034582
J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):680-1
pubmed: 26105173
Neuromuscul Disord. 2021 Aug;31(8):701-705
pubmed: 34244020
Neuromuscul Disord. 2009 May;19(5):308-15
pubmed: 19380227
Neuromuscul Disord. 2009 May;19(5):316-23
pubmed: 19364651
Autophagy. 2021 Dec;17(12):4502-4503
pubmed: 34632910
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Ann Neurol. 2005 Mar;57(3):457-61
pubmed: 15732117
Intern Med. 2021 Jan 1;60(1):141-144
pubmed: 32893227
Neuromuscul Disord. 2016 Aug;26(8):535-47
pubmed: 27312024
Neuromuscul Disord. 2018 Sep;28(9):778-786
pubmed: 30097247
Structure. 2019 Dec 3;27(12):1820-1829.e4
pubmed: 31623962
Clin Rheumatol. 2018 Apr;37(4):1129-1136
pubmed: 29127544
Neurology. 2012 Nov 27;79(22):2201-8
pubmed: 23152587
J Med Genet. 2012 Jan;49(1):41-6
pubmed: 21984748
J Mol Neurosci. 2011 Nov;45(3):522-31
pubmed: 21892620
Lancet. 2013 Mar 9;381(9869):845-60
pubmed: 23465426
Brain. 2014 Nov;137(Pt 11):2897-902
pubmed: 25125609
Brain. 2012 Dec;135(Pt 12):e223; author reply e224
pubmed: 22991237
Eur J Neurol. 2013 Feb;20(2):251-8
pubmed: 22900631
Mol Genet Metab. 2001 Dec;74(4):458-75
pubmed: 11749051
Eur J Neurol. 2012 Mar;19(3):501-9
pubmed: 22040362

Auteurs

Marianela Schiava (M)

John Walton Muscular Dystrophy Research Centre, Newcastle University, and Newcastle Hospitals NHS Foundation Trusts, Newcastle Upon Tyne, UK.

Chiseko Ikenaga (C)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Rocío Nur Villar-Quiles (RN)

APHP, Centre de référence des maladies neuromusculaires, Institut de Myologie, Sorbonne Université, APHP, Hôpital Pitié-Salpêtrière, Paris, France.

Marta Caballero-Ávila (M)

Neuromuscular Disorders Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Ana Topf (A)

Newcastle University and Newcastle Hospitals NHS Foundation Trusts, Newcastle University, Newcastle upon Tyne, UK.

Ichizo Nishino (I)

Department of Neuromuscular Research, National Institute of Neuroscience National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.

Virginia Kimonis (V)

Department of Pediatrics Division of Genetics and Genomic Medicine, University of California-Irvine Medical Center Children's Hospital of Orange County, Orange, California, USA.

Bjarne Udd (B)

Tampere Neuromuscular Center, Tampere University Hospital, Tampere, Finland.
Folkhalsan Genetic Institute, Helsinki University, Helsinki, Finland.

Benedikt Schoser (B)

Department of Neurology, Friedrich-Baur-Institute Ludwig Maximilian University Clinics, Munich, Germany.

Edmar Zanoteli (E)

Department of Neurology, School of Medicine, Universidade de São Paulo (FMUSP), São Paulo, Brazil.

Paulo Victor Sgobbi Souza (PVS)

Disciplina de Neurologia, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.

Giorgio Tasca (G)

Unità Operativa Complessa di Neurologia, Fondazione Policlinico Universitario A Gemelli, IRCCS, Rome, Italy.

Thomas Lloyd (T)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Adolfo Lopez-de Munain (A)

Biodonostia Neurosciences Area Group of Neuromuscular Diseases Biodonostia-Osakidetza Basque Health Service, San Sebastian, Spain.

Carmen Paradas (C)

Neurology Department, Neuromuscular Disorders Unit, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Instituto de Biomedicina de Sevilla, Sevilla, Spain.
Center for Biomedical Network Research on Neurodegenerative Disorders (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.

Elena Pegoraro (E)

Department of Neurosciences, University of Padova, Padova, Italy.

Aleksandra Nadaj-Pakleza (A)

Department of Neurology, Centre de Reference des Maldies Neuromusculaires Nord-Est-Ile de France, University Hospital of Strasbourg, Strasbourg, France.

Jan De Bleecker (J)

Department of Neurology and Neuromuscular Reference Center, Ghent University Hospital, Ghent, Belgium.

Umesh Badrising (U)

Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.

Alicia Alonso-Jiménez (A)

Department of Neurology, Neuromuscular Reference Centre, Antwerp University Hospital, Universiteit Antwerpen, Instituut Born Bunge, Antwerpen, Belgium.

Anna Kostera-Pruszczyk (A)

Department of Neurology, Medical University of Warsaw, European Reference Network ERN-NMD, Warsaw, Poland.

Francesc Miralles (F)

Department of Neurology, Unitat de Patologia Neuromuscular i Gabinet d'electrodiagnòstic, Hospital Universitari Son Espases, Palma de Mallorca, Spain.

Jin-Hong Shin (JH)

Laboratory of Molecular Neurology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.

Jorge Alfredo Bevilacqua (JA)

Unidad Neuromuscular, Departamento de Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago de Chile, Chile.
Departamento de Neurología y Neurocirugía Clínica, Clínica Dávila, Santiago Chile, Chile.

Montse Olivé (M)

Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
Deaprtment of Neurology, Neuromuscular Disorders Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.

Matthias Vorgerd (M)

Heimer Institut for Muscle Research, Klinikum Bergmannsheil, Ruhr University, Bochum, Germany.

Rudi Kley (R)

Department of Neurology and Clinical Neurophysiology, St Marien-Hospital Borken, Borken, Germany.

Stefen Brady (S)

Neurology Department, John Radcliffe Hospital, Oxford, UK.

Timothy Williams (T)

Newcastle Motor Neurone Disease Care Centre, Royal Victoria Infirmary, Newcastle, UK.

Cristina Domínguez-González (C)

Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain.
Neurology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.

George K Papadimas (GK)

First Department of Neurology, Medical School, Eginition Hospital and National and Kapodistrian University of Athens, Athens, Greece.

Jodi Warman-Chardon (J)

Department of Medicine, Ottawa Neuromuscular Centre, Ottawa Hospital, Ottawa, Ontario, Canada.

Kristl G Claeys (KG)

Department of Neurology, University Hospitals Leuven, Leuven, Belgium.
KU Leuven Laboratory for Muscle Diseases and Neuropathies, Leuven, Belgium.

Marianne de Visser (M)

Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands.

Nuria Muelas (N)

Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain.
Neuromuscular Unit, Department of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Neuromuscular and Ataxias Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.

Pascal LaForet (P)

Neurology department, Raymond-Poincaré hospital, APHP, UVSQ, Paris-Saclay University, Paris, France.

Edoardo Malfatti (E)

APHP, Neuromuscular Reference Center Nord-Est-Ile-de-France, Henri Mondor Hospital, Université Paris Est, U955, INSERM, Créteil, IMRB, Paris, France.

Lindsay N Alfano (LN)

Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.

Sruthi S Nair (SS)

Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India.

Georgios Manousakis (G)

Department of Neurology, University of Minnesota Hospital, Minneapolis, Minnesota, USA.

Hani A Kushlaf (HA)

Department of Neurology & Rehabilitation Medicine, University of Cincinnati, Cincinnati, Ohio, USA.

Matthew B Harms (MB)

NewYork Presbyterian Columbia University Irving Medical Centre, New York, New York, USA.

Christopher Nance (C)

Department of Neurology, Carver College of Medicine at the University of Iowa, Iowa, Iowa, USA.

Alba Ramos-Fransi (A)

Neuromuscular Unit, Neurology Department, Hospital Germas Trias i Pujol, Badalona, Spain.

Carmelo Rodolico (C)

Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Channa Hewamadduma (C)

Sheffield Institute for translational neurosciences (SITRAN), Neuroscience Institute, University of Sheffield, Sheffield, UK.

Hakan Cetin (H)

Department of Neurology, Medical University of Vienna, Vienna, Austria.

Jorge García-García (J)

Neurology Department, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.

Endre Pál (E)

Department of Neurology, University of Pécs, Pécs, Hungary.

Maria Elena Farrugia (ME)

Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK.

Phillipa J Lamont (PJ)

Department of Neurology, Royal Perth Hospital, Perth, Western Australia, Australia.

Colin Quinn (C)

Neuromuscular Division, Neurology Department, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Velina Nedkova-Hristova (V)

Neurology Department, Bellvitge University Hospital, Bellvitge, Spain.

Stojan Peric (S)

Neurology Clinic, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Sushan Luo (S)

Department of Neurology, Huashan Hospital Fudan University, Shanghai, China.
National Center for Neurological Disorders, Shanghai, China.

Anders Oldfors (A)

Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.

Kate Taylor (K)

Southern General Hospital, Glasgow, UK.

Stuart Ralston (S)

Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK.

Tanya Stojkovic (T)

APHP, Centre de référence des maladies neuromusculaires, Institut de Myologie, Sorbonne Université, APHP, Hôpital Pitié-Salpêtrière, Paris, France.

Conrad Weihl (C)

Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.

Classifications MeSH